VICTORIA MCGINLEY: Open Payments
NPI 1477997039 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,947 in 177 payments from 13 companies in 2025. Trend: 2023 $1,308 · 2024 $2,204 · 2025 $2,947
Food & beverage: $2,700Education: $247
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 30 | $576 |
| Teva Pharmaceuticals USA, Inc. | 19 | $511 |
| ABBVIE INC. | 19 | $267 |
| Lundbeck LLC | 18 | $252 |
| Janssen Pharmaceuticals, Inc | 14 | $236 |
| Otsuka America Pharmaceutical, Inc. | 21 | $224 |
| Vanda Pharmaceuticals Inc. | 16 | $203 |
| E.R. Squibb & Sons, L.L.C. | 12 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $159 |
| Supernus Pharmaceuticals, Inc. | 9 | $132 |
Products named: INGREZZA, REXULTI, VRAYLAR, FANAPT, UZEDY, INVEGA SUSTENNA, COBENFY, CAPLYTA.
Industry payments across WI — which companies pay providers there.
